Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
24.56
+0.92 (3.89%)
Jul 9, 2026, 4:00 PM EDT - Market closed
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $744.9 million as of July 10, 2026. Its market cap has increased by 34.66% in one year.
Market Cap
744.90M
Enterprise Value
519.94M
1-Year Change
34.66%
Ranking
Category
Stock Price
$24.56
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $744.90M, an increase of 505.36%. That is a compound annual growth rate of 29.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 744.90M | -34.40% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 3.23B |
| GRAIL | 3.01B |
| GeneDx Holdings | 1.95B |
| NeoGenomics | 1.85B |
| Personalis | 1.48B |
| CareDx | 1.42B |
| OPKO Health | 1.06B |
| Fulgent Genetics | 585.34M |